PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

The UK's Post-Brexit Life Sciences Strategy: Outlook and Implications

The Supply Chain: What Price Patient-Centricity?

Using Data to Capture Value

Top Story
Pharm Exec's Industry Audit 2017
With our latest review indicating declines in shareholder value and shareholder value to sales, those companies that score well in critical profit management metrics such as return on invested capital are best positioned to maintain that crucial edge in performance execution
/Read more/
Advertisement
Driving Great Access to Healthcare Professional and Increasing Brand Performance How Virtual Engagement is Becoming a Must Have Component of any Pharmaceutical Sales Strategy
Sponsored by TrialCard
Download Whitepaper
Pricing
Can New Value Framework Ease Friction Over Orphan Drug Prices?
Even on the contentious topic of orphan drug pricing, the last few months have brought hopeful signs that patients, pharmaceutical companies, health insurers, and the academic bodies that counsel them are trying to speak the same language. Lisa Iseneggar reports
/Read more/
Advertisement
Value-Based Strategies for Reimbursement and Formulary Success
ExL’s first annual Value-Based Strategies for Reimbursement and Formulary Success Event is taking place on November 7-8 in Bethesda MD. This event will pioneer the conversation of the transition from price-centric to value-based formularies. Life science and healthcare insurance executives will provide attendees with education in proving value, instead of managing pricing of drugs coming onto the market. Learn more
Strategy
Early Engagement with Payers: 5 Ways to Succeed
As regulators lower evidentiary requirements for approval to speed development/review of new drugs for unmet medical needs, payers are demanding more data to justify price premiums. How can companies can navigate these complexities?
/Read more/
Advertisement
Launching into Value: Pharma’s Quest to Align Drug Prices with Outcomes
Live Webcast: Wednesday, October 11 at 11:00am EDT
Register now
Regulatory
FDA, Industry Prepare for New User Fee Initiatives
Drug pricing, right-to-try, opioids, and OTC improvements still on legislative agenda. Jill Wechsler reports
/Read more/
Advertisement
RIM Best Practices: Unifying Data, Content & Regulatory Processes
On Demand
Learn more
Marketing
The 'Hear' and Now for Social Media
For the life sciences industry in 2017, engaging across social media means less talking—and more listening. Peter Houston reports
/Read more/
Advertisement
15th Annual Global Forum
Sept 25-29, 2017
Hyatt Regency McCormick Place, Chicago, IL

Returning for its 15th iteration, the world’s largest event for temperature-controlled life science supply chains heads back to Chicago this year with a focus on the next generation of temperature control! Join 850+ attendees from 30+ countries for five days of master classes, workshops, track sessions, panel discussions, roundtables, and more. With the Global Forum, your company will meet emerging and ongoing challenges for 2017 and beyond.
Register now
Calendar
/ September 27–28: Finance and Accounting for Bioscience Companies /
New Brunswick, NJ
/ October 24–25: 12th Annual Value-Based Oncology Management /
Scottsdale, AZ
/ October 26–27: MedComm /
San Francisco, CA
/ 14 November: EU GDPR Bootcamp Life Sciences /
London, UK
/ November 15-16: 4th Annual Global Compliance Congress for Life Sciences /
London, UK
/ February 27–28, 2018: Speaker Programs 2018 /
Philadelphia, PA
Advertisement
Accelerate Real World Evidence: Leveraging Data for Faster Time to Insight
Live Webcast: Wednesday, October 18 at 11:00am EDT
Register now
Industry update
//Caris Life Sciences (Irving, TX) appointed W. Michael Korn, M.D.as Chief Medical Officer. //ValGenesis (San Francisco, CA) announced the appointment of Dr. Ajaz Hussain as a member of its Board of Directors and Chairman of Advisory Board. //GSW (Columbus, OH), an INC Research/inVentiv Health company, named Sonja Foster-Storch as President. //PLx Pharma (Houston, TX) appointed Tom Long as Vice President, Manufacturing & Technical Operations, effective immediately, and Steven Valentino as Vice President, Trade Sales, effective October 1. //
Advertisement
How Can Scientific Dissemination Data Help Medical Affairs Adopt a more Strategic Role?
On Demand
Learn more
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com